Vincent Lo Re

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    AIDS 23:2191-8. 2009
  2. pmc Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6073, USA
    Clin Liver Dis 12:587-609, ix. 2008
  3. pmc Incidence of transaminitis among HIV-infected patients with occult hepatitis B
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Virol 43:32-6. 2008
  4. ncbi The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safety
    Vincent Lo Re
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 16:818-25. 2007
  5. ncbi Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 60:294-9. 2007
  6. ncbi Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 44:344-50. 2007
  7. ncbi Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 44:315-20. 2007
  8. ncbi Obstructive sleep apnoea among HIV patients
    V Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Int J STD AIDS 17:614-20. 2006
  9. ncbi William Pepper Jr, MD (1843-1898): portrait of a nineteenth-century medical educator
    Vincent Lo Re
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Med Biogr 14:169-77. 2006
  10. ncbi Eosinophilic meningitis
    Vincent Lo Re
    Division of Infectious Diseases, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Med 114:217-23. 2003

Detail Information

Publications42

  1. pmc Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    AIDS 23:2191-8. 2009
    ..Few studies have examined the impact of viral hepatitis on bone mineral density (BMD), and none have done so among HIV-infected patients. Our objective was to determine whether viral hepatitis was associated with low BMD in HIV...
  2. pmc Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6073, USA
    Clin Liver Dis 12:587-609, ix. 2008
    ....
  3. pmc Incidence of transaminitis among HIV-infected patients with occult hepatitis B
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Virol 43:32-6. 2008
    ..This information is needed to determine the importance of detecting and treating occult HBV in this population...
  4. ncbi The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safety
    Vincent Lo Re
    Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 16:818-25. 2007
    ..We sought to examine ways that academia could expand its role in U.S. drug safety...
  5. ncbi Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 60:294-9. 2007
    ..To determine the validity of self-reported hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-infected injection drug users (IDUs) vs. nonIDUs...
  6. ncbi Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 44:344-50. 2007
    ..Clinical observations suggest that patients with HIV/hepatitis C virus (HCV) may lose body weight during dual therapy, but this has not been confirmed analytically...
  7. ncbi Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 44:315-20. 2007
    ..The prevalence of occult HBV in HIV-infected patients remains controversial, and the risk factors and clinical significance are unknown...
  8. ncbi Obstructive sleep apnoea among HIV patients
    V Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Int J STD AIDS 17:614-20. 2006
    ..Overnight polysomnography can aid in the diagnosis of sleep disturbances...
  9. ncbi William Pepper Jr, MD (1843-1898): portrait of a nineteenth-century medical educator
    Vincent Lo Re
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Med Biogr 14:169-77. 2006
    ..William Pepper Jr was one of the 19th century's foremost medical educators and his accomplishments helped reshape the way medicine was taught throughout the United States...
  10. ncbi Eosinophilic meningitis
    Vincent Lo Re
    Division of Infectious Diseases, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Med 114:217-23. 2003
    ..This review describes the etiologies of eosinophilic meningitis, focusing primarily on the helminths that cause CSF eosinophilia...
  11. ncbi Prevention of malaria in travelers
    Vincent Lo Re
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Am Fam Physician 68:509-14. 2003
    ..Finally, travelers should be instructed to seek medical attention immediately if symptoms of the disease develop during or after the trip...
  12. ncbi Hypereosinophilia associated with cardiac rhabdomyosarcoma
    Vincent Lo Re
    Division of Infectious Diseases, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Am J Hematol 74:64-7. 2003
    ..We describe a patient with hypereosinophilia associated with a cardiac rhabdomyosarcoma, review the etiologies of hypereosinophilia, and discuss the possible mechanisms...
  13. ncbi Fever in the returned traveler
    Vincent Lo Re
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Am Fam Physician 68:1343-50. 2003
    ..Enteric fever is treated with fluoroquinolones, dengue fever with supportive measures only, leptospirosis with penicillin or doxycycline, and rickettsial infections with doxycycline...
  14. ncbi Identifying the vector of Lyme disease
    Vincent Lo Re
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
    Am Fam Physician 69:1935-7. 2004
    ..Administration of amoxicillin is appropriate for pregnant women or children younger than eight years. For those who are allergic to these medications, cefuroxime axetil may be used...
  15. pmc Management of chronic hepatitis C
    V Lo Re
    Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, 502 Johnson Pavilion, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Postgrad Med J 81:376-82. 2005
    ..Combination therapy with weekly subcutaneous pegylated interferon and daily oral ribavirin is the standard of care for treating patients with chronic HCV...
  16. ncbi Travel immunizations
    Vincent Lo Re
    Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Am Fam Physician 70:89-99. 2004
    ..Physicians should be aware of the adverse events and contraindications associated with each travel vaccine...
  17. pmc The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients
    Valerianna K Amorosa
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Antivir Ther 15:91-9. 2010
    ..The aim of this study was to determine if use of abacavir, as well as other antiretrovirals, was associated with reduced response to pegylated interferon (PEG-IFN) plus ribavirin...
  18. pmc Adherence to hepatitis C virus therapy and early virologic outcomes
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104 6021, USA
    Clin Infect Dis 48:186-93. 2009
    ..We examined the relationship between adherence to pegylated interferon and ribavirin therapy, measured by pharmacy refill, and HCV suppression during the initial 12 weeks of therapy...
  19. doi Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:861-72. 2013
    ....
  20. pmc Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    AIDS Behav 17:94-103. 2013
    ..Among HIV/HCV patients, EVR and SVR increased with higher interferon and ribavirin adherence. Adherence to both antivirals declined over time, but more so for ribavirin...
  21. pmc Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    HIV Clin Trials 10:25-32. 2009
    ..Treatment eligibility rates in patients with HCV monoinfection have not been directly compared with patients with HCV/HIV coinfection. These data are important for planning interventions to optimize HCV management...
  22. doi Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients
    Valerianna K Amorosa
    Philadelphia Veterans Affairs Medical Center, Philadelphia, PA 19104, USA
    J Clin Gastroenterol 47:457-60. 2013
    ..However, it is unclear if patients are willing to repeat this procedure...
  23. pmc Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection
    Vincent Lo Re
    Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Hepatology 56:1688-98. 2012
    ..56; 95% CI: 2.93-4.32; males, 18-39 years: HR, 2.40; 95% CI: 2.02-2.84)...
  24. pmc Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
    Vincent Lo Re
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Ann Intern Med 155:353-60. 2011
    ..Adherence to therapy with pegylated interferon and ribavirin for hepatitis C virus (HCV) infection has been incompletely examined...
  25. pmc Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
    Michelle DallaPiazza
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    BMC Infect Dis 10:116. 2010
    ..Since HIV-monoinfected patients do not routinely undergo liver biopsy, we evaluated the prevalence and risk factors of significant hepatic fibrosis in this group using the aspartate aminotransferase (AST)-to-platelet ratio index (APRI)...
  26. ncbi A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
    Robert Gross
    Division of Infectious Diseases, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, Center for Education and Research in Therapeutics, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    J Infect Dis 194:1108-14. 2006
    ....
  27. pmc Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database
    David S Goldberg
    Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:103-7. 2013
    ..The development and validation of such algorithms are necessary for the conduct of population-based studies evaluating the epidemiology and comparative effectiveness and safety of therapies for HCC...
  28. ncbi Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007
    Dana D Byrne
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia
    Ann Epidemiol 24:418-23. 2014
    ..S. Medicaid programs of California, Florida, New York, Ohio, and Pennsylvania between 2000 and 2007. As part of our analyses, we confirmed the accuracy of CHB diagnoses within the Medicaid database...
  29. ncbi Anemia during treatment of hepatitis C in HIV-infected patients
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelpha, Pennsylvania, USA
    AIDS Read 14:555-7, 562, 565-71. 2004
    ..Thus, close monitoring of the hemoglobin level and appropriate management of the anemia that may develop in HIV-infected patients during hepatitis C therapy is essential...
  30. pmc Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus
    Adeel A Butt
    Division of Infectious Diseases, 3601 Fifth Avenue, Suite 3A, Falk Medical Building, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Int J Infect Dis 13:449-55. 2009
    ..Treatment rates for hepatitis C virus (HCV) have not been compared directly between HCV mono-infected and HCV-HIV co-infected patients in academic center settings...
  31. ncbi Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector
    Gregory P Bisson
    Division of Infectious Disease, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 20:1333-6. 2006
    ..001]. HAART costs should be minimized as scale-up efforts in sub-Saharan Africa progress...
  32. pmc Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity
    Ingi Lee
    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 30:1266-74. 2011
    ..However, there have been few studies examining whether HCV infection reduces survival after heart transplantation...
  33. pmc Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection
    Zsofia Szep
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, USA
    AIDS 25:525-9. 2011
    ..Low vitamin D levels increase the risk of type 2 diabetes mellitus, and vitamin D supplementation has been shown to decrease the risk of type 2 diabetes mellitus in patients without HIV infection...
  34. doi Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies
    Vincent Lo Re
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 21:1202-15. 2012
    ..To describe the design and rationale of a series of postmarketing studies to examine the safety of saxagliptin, an oral dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus, in real-world settings...
  35. pmc Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study
    Vincent Lo Re
    Philadelphia VA Medical Center, Philadelphia, PA, USA Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Pharmacoepidemiol Drug Saf 20:689-99. 2011
    ..We determined the ability of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events within the Veterans Aging Cohort Study (VACS)...
  36. ncbi Natural history of patients with low-level HIV viremia on antiretroviral therapy
    Vincent Lo Re
    Division of Infectious Diseases, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    AIDS Patient Care STDS 18:436-42. 2004
    ..Higher initial HIV RNA levels and white race were predictors for virologic increase...
  37. ncbi Erectile dysfunction in an urban HIV-positive population
    Alexander R Ende
    Jonathan Lax Center, Philadelphia FIGHT, Philadelphia, Pennsylvania 19107, USA
    AIDS Patient Care STDS 20:75-8. 2006
    ..These results emphasize the high prevalence of ED in HIV-positive men...
  38. pmc Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection
    Vincent Lo Re
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:807-14. 2009
    ..We determined the accuracy of HCV diagnostic codes within The Health Improvement Network (THIN), an electronic database containing medical record data from general medical practices in the United Kingdom...
  39. ncbi Predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C
    Vincent Lo Re
    Clin Infect Dis 38:1789-90; author reply 1790. 2004
  40. ncbi Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection
    Sara C Keller
    a Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    AIDS Care 26:716-22. 2014
    ..As we showed a low rate of CRCS overall in this Medicaid population, researchers, clinicians, and policy-makers should improve access to and uptake of CRCS among all Medicaid patients, and particularly among PLWH...
  41. pmc Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection
    Brian A Raphael
    Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Am Acad Dermatol 67:962-8. 2012
    ..Chronic hepatitis C virus (HCV) infection is associated with necrolytic acral erythema (NAE). However, the prevalence of NAE among patients with HCV is unknown, and the clinical and histologic features have not been well defined...
  42. ncbi Type III hyperlipoproteinemia unmasked by HIV anti-retroviral therapy
    Frederick F Samaha
    Am J Med 118:691-2. 2005